Regional, international and global clinical trials
Phase I studies
Phase I studies, especially first in man studies, require immediate laboratory testing not just for safety parameters but also for an increasingly wide range of cellular and soluble biomarkers.
SYNLAB Pharma offers local laboratory solutions across Europe for rapid testing; 24 hours per day, 365 days per year.
In addition, SYNLAB Pharma has dedicated laboratory facilities with world-class expertise and state of the art equipment for bioanalysis to support SAD, MAD or DDI studies. We operate a state-of-the-art facility for bioanalysis of small molecules and biopharmaceuticals (LC-MS/MS and ligand-binding assays) in Switzerland - and deliver your study results with Swiss quality and timelines.
Phase II to IV
In addition to the services above, SYNLAB pharma provides regional, international and global central laboratory services for clinical trials run by pharmaceutical and biotech companies as well as by CROs.
For paediatric studies (PIP) SYNLAB Pharma provides age specific visit kits (including microtainers), sample collection systems (e.g. DBS cards) and analytical methods designed to analyse microvolumes.